Clinical trial Recruiting at 2 sites Observational Ages 18 to 65

7T MRI scans for migraine, visual snow, and epilepsy

Official title: High-field MR Imaging in Migraine, Visual Snow and Epilepsy

Run by University of Zurich · NCT05524493 · Data updated 2026-11-12

This project will use high-field 7T MRI to try to find microstructural and network differences in people with migraine, visual snow, or drug‑resistant epilepsy and in healthy volunteers.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment200 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations2 sites (Zurich and 1 other locations)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedJune 30, 2026
Study endsJune 30, 2026
Registry record updatedOctober 8, 2025
Trial IDNCT05524493 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults able to give informed consent who have migraine (≥2 attacks/month), drug‑resistant epilepsy by ILAE criteria, or visual snow syndrome, with stable prophylactic medication for at least two months, and healthy volunteers without migraine or epilepsy for the control group.

Probably not a fit

Patients who are pregnant or breastfeeding, planning pregnancy during the study, recently treated with Botox for migraine (<4 months), unable to undergo 7T MRI (e.g., incompatible implants or severe claustrophobia), or seeking immediate therapeutic interventions are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will recruit people with migraine, visual snow syndrome, drug‑resistant epilepsy, and healthy controls and scan them on a clinical 7T Terra Siemens MRI. Multimodal imaging will include structural, quantitative, diffusion, functional MRI and MR spectroscopy to characterize microstructure and network changes. Participants will also complete clinical assessments and questionnaires (including the HARDSHIP migraine questionnaire) and provide medication history. The goal is to compare disease‑specific brain regions and networks across groups to better understand shared and distinct pathophysiology.

Why it matters

Potential benefit: If successful, the findings could identify imaging signatures that help improve diagnosis and guide future targeted therapies for these disorders.

How similar studies have gone: Previous high‑field and multimodal MRI studies have shown promising microstructural and functional differences in migraine and epilepsy, but combining migraine, visual snow and drug‑resistant epilepsy in a single 7T protocol is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients:

* Patient must be able to read and sign the informed consent form
* Stable prophylactic medication for 2 months prior to MRI
* At leat one of the two criteria applies:
* Patients diagnosed with migraine (with or without aura, episodic or chronic). Diagnosis is ensured by clinical interview (at least 8 weeks prior to MRI). Also, patients complete a migraine questionnaire (HARDSHIP) (at least 8 weeks before MRI). Migraine frequency ≥ 2 migraine attacks/month.
* Patients with drug resistent epilepsy accroding to ILAE crtieria
* Patients with diagnoses of Visual snow syndrome

Healthy participants;

* No migraine (validated by questionnaire) or epilepsy
* Participants must be able to read and sign the informed consent form

Exclusion Criteria:

* Treatment of migraine disease with Botox within \< 4 months before baseline and during the study period
* Pregnant or breastfeeding women
* Intention during the course of the trial to become pregnant
* Women with bilateral ovariectomy, with or without hysterectomy, and postmenopausal women (\>2 years of age) are not considered childbearing.
* Other clinically significant comorbidities (e.g., renal insufficiency, hepatic dysfunction, cardiovascular disease, etc.),
* Known or suspected noncompliance with the protocol, drug or alcohol abuse,
* Patient's inability to follow trial procedures, e.g., due to language problems, mental illness, dementia, etc.,
* Prior participation in the clinical trial
* Enrolment of the investigator, his/ her family members, employees and other dependent persons of the test personnel
* Metallic objects in the body (e.g., splinters, MR incompatible implants).
* Pacemaker
* Claustrophobia
* Obesity (body mass index \> 35 kg/m2)

Where it's running

  • Klinik Lengg
    Zurich, Switzerland
    Recruiting
  • University Hospital Zurich
    Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.